Division of Urology and Andrology (University Hospital St. Pölten)

Medicine and Dentistry

1. Patient 100%
2. Inpatient 72%
3. Development 43%
4. Mortality 43%
5. Peroperative Complication 43%
6. Surgery 34%
7. Cystectomy 31%
8. Prostate Cancer 27%
9. Complication 27%
10. Urinary Diversion 26%
11. Diagnosis 25%
12. Lymph Node 25%
13. Transitional Cell Carcinoma 24%
14. Prostatectomy 23%
15. Recurrence Free Survival 23%
16. Prostate Specific Membrane Antigen 21%
17. Positron Emission Tomography 21%
18. Recurrent Disease 21%
19. Woman 21%
20. Cystoscopy 21%
21. Gallium 68 21%
22. Nephroureterectomy 21%
23. Systemic Therapy 21%
24. Patient Selection 21%
25. Metastatic Carcinoma 21%
26. Ligand 21%
27. Gallium 21%
28. Cytoreductive Surgery 21%
29. Pain 21%
30. Age 17%
31. Accuracy 16%
32. Muscle Invasive Bladder Cancer 15%
33. Analysis 13%
34. Upper Urinary Tract 13%
35. Elderly Patient 8%
36. Odds Ratio 8%
37. Predictor 8%
38. Biochemical Recurrence 8%
39. Diseases 7%
40. Follow up 7%
41. Proportional Hazards Model 7%
42. Diagnostic Accuracy 7%
43. Wound Complication 6%
44. Postoperative Complication 6%
45. Logistic Regression Analysis 6%
46. Regression Analysis 5%
47. Prostate Specific Antigen 5%
48. Gleason Score 5%
49. Lymph Node Metastasis 5%